Nadhila Pratiwi, - and Muhtarum Yusuf, - (2020) Side Effects of Drugs in Patients with Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy. International Journal of Pharmaceutical Research, 12 (4). pp. 1511-1516. ISSN 0975-2366

	Text (Bukti Korespondensi) Bukti Korespondensi 6.pdf Download (121kB)
	Text (Karil) Karil 6.pdf Download (114kB)
	Text (Artikel) Artikel 6.pdf Download (3MB)
	Text (Similarity) C6 Turnitin.pdf Download (1MB)
	Text (Bukti Etik) Bukti Etik 6.pdf Download (301kB)

Abstract

Background: Nasopharyngeal carcinoma (NPC) therapy includes radiation, chemotherapy, or a combination of both. The purpose of this study was to determine the incidence of drug side effects in NPC patients receiving neoadjuvant chemotherapy. Methods: This was a retrospective descriptive study using secondary data in the form of medical records at Dr. Soetomo Hospital, Surabaya, from January 1 to December 31, 2018. Results: Comparison of the number of patients with the incidence of side effects of chemotherapy drugs was 1:3.8. Anemia was the most side effect of chemotherapy drugs with 85 cases (24.85%), followed by hypocalcemia with 78 cases (22.81%), and hyponatremia with 60 cases (17.54%). Leukopenia was the rarest type of side effect of chemotherapy drugs, with only one in 342 cases (0.29%). Based on the degree, it was found that the most side effects of chemotherapy drugs were first degree with 253 cases (73.98%), followed by second degree with 78 cases (22.81%), third degree with 9 cases (2.63%), and degree IV with 2 cases (0.58%). There were no side effects of grade V drugs in the samples. Conclusion: The incidence of side effects of neoadjuvant chemotherapy drugs was 77.24% with the most side effects of anemia.

Actions (login required)

View Item